15 days ago
CGON
AnalystsJeffrey HungJeffrey Hung's Stock Forecasts
AnalystsJeffrey Hung
Sectors:
Analyst Ranking
Top 21%
#1035 out of 4923 analysts
Average Return
+4.17%
Win Rate
47%47 out of 99
Risk vs Reward
Poor
Good
Jeffrey Hung's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Myokardia IncMYOK | +314.95% | $53.26 | $221.00 | 2020-04-14 - 2020-10-06 | Strong Buy |
Cytokinetics IncCYTK | +182.40% | $33.19 | $93.73 | 2023-08-03 - 2024-01-05 | Strong Buy |
Cytokinetics IncCYTK | +151.83% | $37.22 | $93.73 | 2023-06-21 - 2024-01-05 | Strong Buy |
Disc Medicine IncIRON | +108.90% | $28.10 | $58.70 | 2023-04-19 - 2023-12-19 | Strong Buy |
Evofem Biosciences IncEVFM | +95.55% | $10.75 | $0.48 | 2021-10-13 - 2022-08-10 | Strong Sell |
Jeffrey Hung Analyst Color
Get additional color on Jeffrey Hung's coverage of popular stocks
4 months ago
PTCT
4 months ago
JAZZ
5 months ago
NBIX
7 months ago
PTCT
9 months ago
ITCI
9 months ago
CNTA
a year ago
NBIX
2 years ago
RYTM
2 years ago
FOLD
2 years ago
BLUE
Jeffrey Hung's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cg Oncology IncCGON | 4 | Strong Buy | $56.00 | +115.38% | Maintains | 15 days ago |
Acadia Pharmaceuticals IncACAD | 20 | Hold | $24.00 | +11.27% | Maintains | a month ago |
Contineum Therapeutics IncCTNM | 3 | Strong Buy | $20.00 | +403.78% | Maintains | a month ago |
Ultragenyx Pharmaceutical IncRARE | 7 | Strong Buy | $65.00 | +78.77% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 6 | Strong Buy | $166.00 | +56.43% | Maintains | 2 months ago |
Bicycle Therapeutics PLCBCYC | 5 | Hold | $17.00 | +144.60% | Maintains | 2 months ago |
Engene Holdings IncENGN | 3 | Strong Buy | $34.00 | +834.07% | Maintains | 4 months ago |
Rhythm Pharmaceuticals IncRYTM | 10 | Strong Buy | $72.00 | +13.94% | Assumes | 4 months ago |
Ptc Therapeutics IncPTCT | 11 | Strong Buy | $70.00 | +43.33% | Assumes | 4 months ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $150.00 | +19.34% | Assumes | 4 months ago |
Erasca IncERAS | 3 | Strong Buy | $4.00 | +214.96% | Assumes | 4 months ago |
Disc Medicine IncIRON | 6 | Strong Buy | $85.00 | +60.50% | Assumes | 4 months ago |
Cullinan Therapeutics IncCGEM | 5 | Strong Buy | $35.00 | +364.81% | Assumes | 4 months ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Strong Buy | $27.00 | +105.48% | Assumes | 4 months ago |
Bioage Labs IncBIOA | 2 | Strong Sell | $5.00 | +21.07% | Assumes | 4 months ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $67.00 | +102.78% | Upgrades | 5 months ago |
Amicus Therapeutics IncFOLD | 4 | Hold | $12.00 | +109.42% | Downgrades | 7 months ago |
Intra Cellular Therapies IncITCI | 5 | Strong Buy | $95.00 | -27.96% | Maintains | 9 months ago |
Cervomed IncCRVO | 1 | Strong Buy | $35.00 | +456.88% | Initiates Coverage On | a year ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Strong Buy | $70.00 | N/A | Maintains | a year ago |
Karuna Therapeutics IncKRTX | 3 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Prelude Therapeutics IncPRLD | 6 | Strong Sell | $4.00 | N/A | Downgrades | 2 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Sell | $4.00 | N/A | Downgrades | 2 years ago |
Invivyd IncIVVD | 1 | Hold | $4.00 | N/A | Upgrades | 2 years ago |
Bluebird Bio IncBLUE | 1 | Hold | $140.00 | N/A | Upgrades | 2 years ago |
Immuneering CorpIMRX | 3 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Esperion Therapeutics IncESPR | 7 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Repare Therapeutics IncRPTX | 5 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Lenz Therapeutics IncLENZ | 4 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Cyteir Therapeutics IncCYTT | 3 | Strong Sell | $2.00 | N/A | Downgrades | 2 years ago |
Celularity IncCELU | 3 | Strong Sell | $10.00 | N/A | Downgrades | 2 years ago |
Cincor Pharma IncCINC | 6 | Hold | $30.00 | N/A | Maintains | 2 years ago |
Exelixis IncEXEL | 2 | Hold | $22.00 | N/A | Maintains | 3 years ago |
Rubius Therapeutics IncRUBY | 3 | Hold | $1.50 | N/A | Maintains | 3 years ago |
Evofem Biosciences IncEVFM | 6 | Strong Sell | $0.75 | N/A | Maintains | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $146.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Aprea Therapeutics IncAPRE | 5 | Strong Sell | $60.00 | N/A | Downgrades | 4 years ago |
Voyager Therapeutics IncVYGR | 2 | Hold | $7.00 | N/A | Maintains | 4 years ago |
Myokardia IncMYOK | 2 | Hold | $225.00 | N/A | Downgrades | 5 years ago |
Nextcure IncNXTC | 1 | Strong Buy | $58.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.